Chapter

TERMINALLY ILL PATIENT’S RIGHT TO TRY INVESTIGATIONAL DRUGS, BIOLOGICAL PRODUCTS, AND DEVICES

O.C.G.A. § 31-52-1— Short title
O.C.G.A. § 31-52-2— Legislative findings
O.C.G.A. § 31-52-3— Definitions
O.C.G.A. § 31-52-4— Eligibility criteria
O.C.G.A. § 31-52-5— Written informed consent
O.C.G.A. § 31-52-6— Manufacturers permitted to make investigational drugs, biological products, or devices available
O.C.G.A. § 31-52-7— Coverage under health benefit plan permitted but not required
O.C.G.A. § 31-52-8— Physician immunity from sanction for recommending, prescribing, or treating with investigational drugs, biological products, or devices
O.C.G.A. § 31-52-9— State prohibited from blocking eligible patient access
O.C.G.A. § 31-52-10— Statutory construction